Home > Pharmaceuticals And Healthcare > Radiopharmaceuticals Market Size 2024 to 2031

Radiopharmaceuticals Market Size 2024 to 2031

The prevalence of cancer is increasing at the global level. For instance, according to the Global Cancer Observatory, approximately 19,292,789 new cases of cancer were detected worldwide in 2020. Among these, 10,065,305 new cases were diagnosed in the global male population. Also, the most common Product Types of cancer diagnosed in males in 2020 were lung cancer accounting for 14.3% of the total cases, followed by prostate cancer at 14.1%, colorectal cancer at 10.6%, and stomach cancer at 7.1% of the total cases respectively. Thus, the increasing prevalence of cancer is accelerating the demand for radiopharmaceuticals to administrate intravenously to be delivered to a target tumor. This prime factor is accelerating market growth.

ID : IL_612 | Language's : En/Jp/Fr/De | Publisher : IL | Format : ms word ms Excel PPT PDF

Table of Content
  1. Introduction
    1. Market Introduction
    2. Market Research Methodology
      1. Research Process
      2. Primary Research
      3. Secondary Research
      4. Data Collection Technique
      5. Data Sources
    3. Market Estimation Methodology
      1. Limitations of the Study
    4. Product Picture of Radiopharmaceuticals
    5. Years Considered for the Study
    6. Parent Market Overview
    7. Overall Radiopharmaceuticals Market Regional Demand
    8. Data Source
      1. Secondary Sources
      2. Primary Sources
  2. Executive Summary
    1. Business Trends
    2. Regional Trends
  3. Market Dynamics
    1. Drivers
      1. Drivers
    2. Restraints
      1. Restraints
    3. Opportunities
    4. Impact Forces During the Forecast Years
    5. Industry Value Chain
      1. Upstream Analysis
      2. Downstream Analysis
      3. Marketing & Distribution Channel
        1. Direct Channel
        2. Indirect Channel
    6. Potential Customers
    7. Manufacturing/Operational Cost Analysis
    8. Key Technology Landscape
    9. Porter’s Analysis
      1. Supplier Power
      2. Buyer Power
      3. Substitution Threat
      4. Threat from New Entry
      5. Competitive Rivalry
    10. PESTEL Analysis
      1. Political Factors
      2. Economic Factors
      3. Social Factors
      4. Technological Factors
      5. Environmental Factors
      6. Legal Factors
  4. Global Radiopharmaceuticals Market Segmentation, by Revenue (USD Million), (2024-2031)
  5. Global Radiopharmaceuticals Market Overview, By Region
    1.  North America Radiopharmaceuticals Market Revenue (USD Million), by Countries, (2024-2031)
      1. U.S.
      2. Canada
      3. Mexico
    2. Europe Radiopharmaceuticals Market Revenue (USD Million), by Countries, (2024-2031)
      1. Germany
      2. France
      3. UK
      4. Spain
      5. Russia
      6. Italy
      7. BENELUX
    3. Asia Pacific Radiopharmaceuticals Market Revenue (USD Million), by Countries, (2024-2031)
      1. China
      2. Japan
      3. Australia
      4. South Korea
      5. India
      6. ASEAN
    4. Latin America Radiopharmaceuticals Market Revenue (USD Million), by Countries, (2024-2031)
      1. Brazil
      2. Argentina
      3. Chile
    5. Middle East and Africa Radiopharmaceuticals Market Revenue (USD Million), by Countries, (2024-2031)
      1. GCC
      2. Turkey
      3. South Africa
  6. Competitive Analysis
    1. Radiopharmaceuticals Market
      1. Business Overview
      2. Business Financials (USD Million)
      3. Product Category, Type, and Specification
      4. Main Business/Business Overview
      5. Geographical Analysis
      6. Recent Development
      7. SWOT Analysis
  7. Market Research Findings & Conclusion
Disclaimer

Purchase to Read Full Report

report-detail Proceed to Buy

Download Sample Report

Insights Leader is product of Consegic Business Intelligence Pvt Ltd © Insights Leader | All Rights Reserved
en_USEnglish
de_DEGerman jaJapanese fr_FRFrench es_ESSpanish zh_TWChinese sv_SESwedish nl_NL_formalDutch pl_PLPolish en_USEnglish